References
1. Lee SH, Tai CT, Hsieh MH, et al. Predictors of non-pulmonary vein
ectopic beats initiating paroxysmal atrial fibrillation: Implication for
catheter ablation. J Am Coll Cardiol 2005;46:1054–9.
2. Ulphani JS, Arora R, Cain JH, et al. The ligament of Marshall as a
parasympathetic conduit. Am J Physiol Heart Circ Physiol
2007;293:1629–35.
3. Kim DT, Lai AC, Hwang C, et al. The ligament of Marshall: A
structural analysis in human hearts with implications for atrial
arrhythmias. J Am Coll Cardiol 2000;36:1324–7.
4. Kamanu S, Tan AY, Peter CT, et al. Vein of Marshall activity during
sustained atrial fibrillation. J Cardiovasc Electrophysiol
2006;17:839–46.
5. Báez-Escudero JL, Keida T, Dave AS, et al. Ethanol infusion in the
vein of Marshall leads to parasympathetic denervation of the human left
atrium: implications for atrial fibrillation. J Am Coll Cardiol
2014;63:1892–1901.
6. Hayashi T, Fukamizu S, Mitsuhashi T, et al. Peri-Mitral Atrial
Tachycardia Using the Marshall Bundle Epicardial Connections. J Am Coll
Cardiol EP 2016;2:27–35.
7. Vlachos K, Denis A, Takigawa M, et al. The role of Marshall bundle
epicardial connections in atrial tachycardias after atrial fibrillation
ablation. Heart Rhythm 2019;16:1341–7.
8. Jais P, Hocini M, Hsu LF, et al. Technique and results of linear
ablation at the mitral isthmus. Circulation 2004;110:2996–3002.
9. Knecht S, Hocini M, Wright M, et al. Left atrial linear lesions are
required for successful treatment of persistent atrial fibrillation. Eur
Heart J 2008;29:2359–66.
10. Knecht S, Wright M, Sacher F, et al. Relationship between perimitral
and peritricuspid conduction times. Heart Rhythm 2008;5:400–5.
11. Valderrábano M, Liu X, Sasaridis C, et al. Ethanol infusion in the
vein of Marshall: Adjunctive effects during ablation of atrial
fibrillation. Heart Rhythm 2009;6:1552–8.
12. Báez-Escudero JL, Morales PF, Dave AS, et al. Ethanol infusion in
the vein of Marshall facilitates mitral isthmus ablation. Heart Rhythm
2012;9:1207–15.
13. Liu CM, Lo LW, Lin YJ, et al. Long-term efficacy and safety of
adjunctive ethanol infusion into the vein of Marshall during catheter
ablation for nonparoxysmal atrial fibrillation. J Cardiovasc
Electrophysiol 2019;30:1215–28.
14. Takigawa M, Vlachos K, Martin CA, et al. Acute and mid-term outcome
of ethanol infusion of vein of Marshall for the treatment of perimitral
flutter. Europace 2020;22:1252–60.
15. Kawaguchi N, Okishige K, Yamauchi Y, et al. Clinical impact of
ethanol infusion into the vein of
Marshall on the mitral isthmus area evaluated by atrial electrograms
recorded inside the coronary sinus. Heart Rhythm 2019;16:1030–8
16. Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation
for persistent atrial fibrillation. N Engl J Med 2015;372:1812‐1822.
17. Valderrábano M, Peterson LE, Bunge R, et al. Vein of Marshall
ethanol infusion for persistent
atrial fibrillation: VENUS and MARS clinical trial design. Am Heart J
2019;215:52–61.
18. Valderrábano M, Peterson LE, Swarup V, et al. Effect of catheter
ablation with vein of Marshall ethanol infusion vs catheter ablation
alone on persistent atrial fibrillation: The VENUS randomized clinical
trial. JAMA 2020;324:1620–8.
19. Nakashima T, Pambrun T, Vlachos K, et al. Impact of Vein of Marshall
Ethanol Infusion on
Mitral Isthmus Block. Circ Arrhythm Electrophysiol 2020;13:e008884.
20. Yamaguchi T, Fukui A, Node K, et al. Bipolar voltage mapping for the
evaluation of atrial substrate: Can we overcome the challenge of
directionality? J Atr Fibrillation 2019;11:2116.